New COVID-19 cases doubled in U.S. in past three weeks
Jul 14, 2021
As cases climb, health authorities in places such as Los Angeles County and St. Louis are begging even the fully vaccinated to don their masks in public.
Adults with IBD show antibody response to mRNA COVID-19 vaccine
Nov 09, 2021
After mRNA COVID-19 vaccination, 99% of patients with inflammatory bowel disease had detectable antibodies regardless of immunocompromising therapies.
Healthy, plant-based diet tied to lower COVID-19 risk
Sep 13, 2021
The association seems to be particularly pronounced among individuals living in areas with higher socioeconomic deprivation.
Circulation of respiratory viruses low during COVID-19 pandemic
Jul 23, 2021
Influenza activity decreased in March 2020 and remained low through May 2021. A decrease was seen in other viruses, with no increase until spring 2021.
mRNA COVID-19 vaccines immunogenic in immunosuppressed patients
Sep 08, 2021
mRNA-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines appear to be immunogenic in patients receiving immunosuppressive medications for the management of chronic inflammatory...
Low vitamin D levels tied to higher risk for COVID-19 infection
Aug 11, 2021
The risk for COVID-19 infection was greater among U.S. Black women with serum levels of vitamin D lower than 20 ng/mL.
Severe COVID-19 rates low with monoclonal antibody therapy during delta surge
Jul 06, 2022
The rates of severe disease were low for high-risk patients with mild-to-moderate COVID-19 treated with antispike monoclonal antibodies.
Veterans report low rates of adverse events with mRNA vaccines
Jun 16, 2022
Rates were slightly higher at 42 days for those receiving the Pfizer versus Moderna vaccine.
COVID-19 incidence not increased with corticosteroid injections
Jul 13, 2022
The incidence of COVID-19 was lower for adults receiving image-guided corticosteroid injections for pain management.
Evidence updated on myocarditis after mRNA COVID-19 vaccination
Aug 02, 2022
The incidence of myocarditis is probably higher after vaccination with mRNA-1273 (Moderna) versus BNT162b2 (Pfizer) and lower with an increased interval between doses.